# Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

> **NCT04282850** · NA · TERMINATED · sponsor: **Inova Health Care Services** · enrollment: 13 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Failure With Normal Ejection Fraction

## Interventions

- **PROCEDURE:** Pulmonary Vein Isolation

## Key facts

- **NCT ID:** NCT04282850
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-10
- **Primary completion:** 2026-02-26
- **Final completion:** 2026-02-26
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** enrollment was not keeping up with technology advancements. PI felt the data would not be pertinent
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04282850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04282850, "Ablation Versus Medical Management of Atrial Fibrillation in HFpEF". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04282850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*